Healthy CD4+ T Lymphocytes are Not Affected by Targeted Therapies Against the PI3K/Akt/mTOR Pathway in T-cell Acute Lymphoblastic Leukemia
Author
McCubrey, James A.
Date
2016-08-23
Citation:
APA:
McCubrey, James A.. (August 2016).
Healthy CD4+ T Lymphocytes are Not Affected by Targeted Therapies Against the PI3K/Akt/mTOR Pathway in T-cell Acute Lymphoblastic Leukemia.
,
(),
-
. Retrieved from
http://hdl.handle.net/10342/9592
MLA:
McCubrey, James A..
"Healthy CD4+ T Lymphocytes are Not Affected by Targeted Therapies Against the PI3K/Akt/mTOR Pathway in T-cell Acute Lymphoblastic Leukemia". .
. (),
August 2016.
April 27, 2024.
http://hdl.handle.net/10342/9592.
Chicago:
McCubrey, James A.,
"Healthy CD4+ T Lymphocytes are Not Affected by Targeted Therapies Against the PI3K/Akt/mTOR Pathway in T-cell Acute Lymphoblastic Leukemia," , no.
(August 2016),
http://hdl.handle.net/10342/9592 (accessed
April 27, 2024).
AMA:
McCubrey, James A..
Healthy CD4+ T Lymphocytes are Not Affected by Targeted Therapies Against the PI3K/Akt/mTOR Pathway in T-cell Acute Lymphoblastic Leukemia. .
August 2016;
():
.
http://hdl.handle.net/10342/9592. Accessed
April 27, 2024.
Collections